ATE78161T1 - 4-aroylimidazol-2-on enthaltende pharmazeutische zusammensetzung. - Google Patents

4-aroylimidazol-2-on enthaltende pharmazeutische zusammensetzung.

Info

Publication number
ATE78161T1
ATE78161T1 AT89101268T AT89101268T ATE78161T1 AT E78161 T1 ATE78161 T1 AT E78161T1 AT 89101268 T AT89101268 T AT 89101268T AT 89101268 T AT89101268 T AT 89101268T AT E78161 T1 ATE78161 T1 AT E78161T1
Authority
AT
Austria
Prior art keywords
aroylimidazole
pharmaceutical composition
composition containing
pharmaceutical
composition
Prior art date
Application number
AT89101268T
Other languages
English (en)
Inventor
Jack Domet
Douglas W Danielson
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Application granted granted Critical
Publication of ATE78161T1 publication Critical patent/ATE78161T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT89101268T 1988-01-29 1989-01-25 4-aroylimidazol-2-on enthaltende pharmazeutische zusammensetzung. ATE78161T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14980388A 1988-01-29 1988-01-29
EP89101268A EP0326103B1 (de) 1988-01-29 1989-01-25 4-Aroylimidazol-2-on enthaltende pharmazeutische Zusammensetzung

Publications (1)

Publication Number Publication Date
ATE78161T1 true ATE78161T1 (de) 1992-08-15

Family

ID=22531858

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89101268T ATE78161T1 (de) 1988-01-29 1989-01-25 4-aroylimidazol-2-on enthaltende pharmazeutische zusammensetzung.

Country Status (17)

Country Link
EP (1) EP0326103B1 (de)
JP (1) JPH01226817A (de)
KR (1) KR890011594A (de)
CN (1) CN1035242A (de)
AR (1) AR241632A1 (de)
AT (1) ATE78161T1 (de)
AU (1) AU611757B2 (de)
DE (1) DE68902056T2 (de)
DK (1) DK169566B1 (de)
ES (1) ES2051898T3 (de)
GR (1) GR3005792T3 (de)
HU (1) HUT49282A (de)
IE (1) IE62426B1 (de)
IL (1) IL89049A0 (de)
NZ (1) NZ227700A (de)
PT (1) PT89561B (de)
ZA (1) ZA89552B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69129918T2 (de) * 1990-03-23 1999-02-04 Yoshitomi Pharmaceutical Ein in Wasser schwerlösliches Arzneimittel enthaltende pharmazeutische Zubereitung
EP1699436A2 (de) * 2003-12-12 2006-09-13 Myogen, Inc. Enoximon-formulierungen und ihre verwendung bei der behandlung von herzhypertrophy und herzinsuffizienz
CA2572179A1 (en) * 2004-06-23 2006-01-19 Myogen, Inc. Enoximone formulations and their use in the treatment of pde-iii mediated diseases
EP2581082B1 (de) 2011-10-10 2015-12-30 Carinopharm GmbH Pharmazeutische Zusammensetzung zur Behandlung von Status asthmaticus

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405635A (en) * 1979-06-18 1983-09-20 Merrell Dow Pharmaceuticals Inc. 4-Aroylimidazol-2-ones and their use as pharmaceuticals
EP0031603A1 (de) * 1979-12-31 1981-07-08 American Cyanamid Company Pharmazeutische Zusammensetzung eines Grundstoffs
NZ197796A (en) * 1980-08-04 1984-11-09 Merck & Co Inc Stabilised aqueous formulations containing ivermectin
DE3307422A1 (de) * 1983-03-03 1984-09-06 Bayer Ag, 5090 Leverkusen Fluessigzubereitungen von dihydropyridinen, ein verfahren zu ihrer herstellung, sowie ihre verwendung bei der bekaempfung von erkrankungen
EP0179583A1 (de) * 1984-10-04 1986-04-30 Merck & Co. Inc. System zur Verbesserung der Auflösungsgeschwindigkeit in Wasser und der Löslichkeit von schwer löslichen Arzneimitteln

Also Published As

Publication number Publication date
DK37589D0 (da) 1989-01-27
EP0326103A1 (de) 1989-08-02
PT89561B (pt) 1994-01-31
CN1035242A (zh) 1989-09-06
IE62426B1 (en) 1995-02-08
NZ227700A (en) 1990-09-26
AR241632A1 (es) 1992-10-30
PT89561A (pt) 1989-10-04
KR890011594A (ko) 1989-08-21
DK169566B1 (da) 1994-12-05
ZA89552B (en) 1989-10-25
IL89049A0 (en) 1989-08-15
ES2051898T3 (es) 1994-07-01
HUT49282A (en) 1989-09-28
EP0326103B1 (de) 1992-07-15
IE890275L (en) 1989-07-29
AU611757B2 (en) 1991-06-20
DE68902056T2 (de) 1992-12-03
JPH01226817A (ja) 1989-09-11
DE68902056D1 (de) 1992-08-20
DK37589A (da) 1989-07-30
GR3005792T3 (de) 1993-06-07
AU2876889A (en) 1989-08-03

Similar Documents

Publication Publication Date Title
DE68901417D1 (de) Pharmazeutische zusammensetzung.
DE3863963D1 (de) Pharmazeutische zusammensetzungen.
DE122004000023I2 (de) Pharmazeutische Zusammensetzung
DE3868986D1 (de) Pharmazeutische zusammensetzungen.
DE69101931D1 (de) Pharmazeutische Zusammensetzung.
FI901102A0 (fi) Farmaceutiska kompositioner.
FI922364A0 (fi) Farmaceutiska kompositioner.
ATE98480T1 (de) Arzneimittelformulierungen.
DE3784594D1 (de) Mikrokapseln enthaltende pharmazeutische zusammensetzungen.
ATA129892A (de) Pharmazeutische zusammensetzung
FI895681A0 (fi) Farmaceutisk komposition foer systemisk transdermal tillfoersel.
ATE71837T1 (de) Pharmazeutische zusammensetzung mit verzoegerter wirkstoffabgabe.
IT1232677B (it) Composizione farmaceutica contenente ranitidina
DE3485408D1 (de) Pharmazeutische zusammensetzung.
DE69006094D1 (de) Pharmazeutische Zusammensetzungen.
IT8820386A0 (it) Composizioni farmaceutiche orosolubili contenti acetilcisteina.
FI893643A (fi) Farmaceutiska kompositioner.
DE68918847D1 (de) Stabile pharmazeutische zusammensetzung.
DE3882157D1 (de) Nichtsteroide antientzuendungswirkstoffe enthaltende pharmazeutische zubereitungen.
DE3682083D1 (de) Pharmazeutische zusammensetzungen.
FI883673A (fi) Farmaceutiska kompositioner.
DE3674040D1 (de) Pharmazeutische zusammensetzungen.
DE68915203D1 (de) Pharmazeutische Mischungen.
DE3866789D1 (de) Pharmazeutische zusammensetzungen.
ATE78161T1 (de) 4-aroylimidazol-2-on enthaltende pharmazeutische zusammensetzung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time